版权说明 操作指南
首页 > 成果 > 详情

Synthesis and anti-thyroid cancer effect of iodo-chrysin derivatives

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Wei, Yun;Zheng, Qutong;Tang, Guotao;Song, Chen;Wang, Guan;...
通讯作者:
Zheng, Xing
作者机构:
[Song, Chen; Xiao, Yan; Wang, Zongbao; Wang, Guan; Zheng, Qutong; Wei, Yun; Tang, Guotao; Zhang, Yinxiang; Zeng, Xianliang; Zheng, Xing] Univ South China, Inst Pharm & Pharmacol, Hengyang 421001, Peoples R China.
[Song, Chen; Xiao, Yan; Wang, Zongbao; Wang, Guan; Zheng, Qutong; Wei, Yun; Tang, Guotao; Zhang, Yinxiang; Zeng, Xianliang; Xiao, Jichang; Zheng, Xing] Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang 421001, Peoples R China.
[Song, Chen; Wang, Guan; Zhang, Yinxiang] Univ South China, Res Interest Grp Pharm, Hengyang 421001, Peoples R China.
[Xiao, Jichang] Chinese Acad Sci, Shanghai Inst Organ Chem, Key Lab Organofluorine Chem, Shanghai 200032, Peoples R China.
通讯机构:
[Zheng, Xing] U
Univ South China, Inst Pharm & Pharmacol, Hengyang 421001, Peoples R China.
语种:
英文
关键词:
Anti-thyroid cancer;activities;Baker-Venkataraman reaction;flavonoids;iodo-chrysin derivatives;MTT method.
期刊:
MEDICINAL CHEMISTRY
ISSN:
1573-4064
年:
2016
卷:
12
期:
5
页码:
441-447
基金类别:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273537]; Scientific Research Fund of Hunan Provincial Education DepartmentHunan Provincial Education Department [12K095]; key disciplines of Hunan Province
机构署名:
本校为第一且通讯机构
院系归属:
药学与生物科学学院
摘要:
A novel series of iodo-chrysin derivatives with resorcinol as raw materials were synthesized according to Baker-Venkataraman reaction and their inhibitory activities in vitro against thyroid cancer cell lines (SW-579 and TT) were evaluated by the standard methyl thiazole tetrazolium (MTT) method. Biological test results showed that these derivatives possessed stronger anti-thyroid cancer activities than 5-FU. Compound 21 showed the strongest activity against SW-579 cell lines with IC50 value of 3.4μM and compound 10 showed the strongest activi...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com